Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are anticipating strong results driven by the continued success of Lilly's blockbuster treatments, particularly its insulin portfolio. However, there are also concerns about potential headwin… Read More